In our study, similar to the results of the meta‐analysis study, body weight, BMI values, and anti‐TPO and anti‐Tg levels of the patients decreased significantly; however, this was not significant across groups, obese patients were not included in the study to evaluate the effectiveness of the intervention better because of the need for medication and treatment caused by metabolic disorders. The gene discussed is TG; the disease is Other metabolic disease.